Nexgard Combo Spot-On Anti-parasitic Solution for Cats - 1 Box (3 applicators)

DESCRIPTION

All cats need parasite protection—even indoor cats. Formulated specifically for cats, NexGard COMBO topical solution is the first and only broad-spectrum parasiticide for cats that:

• Kills fleas and ticks
• Prevents heartworm disease
• Treats and controls roundworms, hookworms, and tapeworms 

PRODUCT DETAILS

• Rapidly kill fleas and ticks
• Treats and control flea allergy dermatitis (FAD)
• Treat ear mites
• Prevent heartworms diseases
• Treats roundworms, hookworms, vesical worms, and tapeworms
• Protection from 8 weeks of age and 0.8kg bodyweight
• Safe in pregnant and lactating queens
• Prevent and treat lungworms diseases

INSTRUCTIONS

1. PULL THE PLUNGER - Remove the applicator from its blister and pull the plunger slightly backwards.

2. REMOVE THE CAP - Twist and remove the cap from the applicator.

3. PART THE HAIR - Using your fingertips, part the hair of your cat on the midline of the neck.

4. APPLY - Place the tip of the applicator in contact with the skin and apply the content in one spot.

SAFETY PROFILE

All medicines, including veterinary medicines, carry benefits and risks. NexGard® COMBO contains the active ingredient esafoxolaner. Esafoxolaner is part of the isoxazoline family of chemicals. Adverse reactions to this family of chemicals are rarely observed but may include vomiting, diarrhoea, lethargy, inappetence (loss of appetite), itching and very rarely, seizures. Most adverse reactions are mild, self-limiting and of short duration. For cats with a history of epilepsy or other seizure disorders, it is recommended to seek veterinary advice prior to treatment with medicines of this class. Eprinomectin and praziquantel are the other active ingredient in NexGard® COMBO. Adverse reactions to eprinomectin and praziquantel are rarely observed at recommended doses.

Rigorous safety studies demonstrate NexGard® COMBO excellent safety profile. This is further supported by Boehringer Ingelheim’s rigorous pharmacovigilance program which closely monitors and evaluates any suspected adverse events reported to the company by pet owners or veterinarians in all countries where the product is registered.